Growth Metrics

Boston Scientific (BSX) Total Debt (2016 - 2026)

Boston Scientific's Total Debt history spans 18 years, with the latest figure at $11.0 billion for Q1 2026.

  • On a quarterly basis, Total Debt fell 2.48% to $11.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $11.0 billion, a 2.48% decrease, with the full-year FY2025 number at $11.4 billion, up 6.42% from a year prior.
  • Total Debt hit $11.0 billion in Q1 2026 for Boston Scientific, down from $11.4 billion in the prior quarter.
  • Over the last five years, Total Debt for BSX hit a ceiling of $11.6 billion in Q3 2025 and a floor of $8.6 billion in Q3 2022.
  • Historically, Total Debt has averaged $10.1 billion across 5 years, with a median of $10.6 billion in 2024.
  • Biggest five-year swings in Total Debt: fell 5.51% in 2022 and later increased 22.32% in 2024.
  • Tracing BSX's Total Debt over 5 years: stood at $8.9 billion in 2022, then rose by 1.87% to $9.1 billion in 2023, then rose by 18.06% to $10.7 billion in 2024, then grew by 6.42% to $11.4 billion in 2025, then decreased by 3.56% to $11.0 billion in 2026.
  • Business Quant data shows Total Debt for BSX at $11.0 billion in Q1 2026, $11.4 billion in Q4 2025, and $11.6 billion in Q3 2025.